Purified Mouse Anti-RUNX3  Clone  R3-5G4   (RUO)

Brand
BD Pharmingen™
Alternative Name
AML2; AML-2; CBFA3; PEBP2aC; PEBP2A3
Concentration
0.5 mg/ml
Isotype
Mouse BALB/c IgG1, κ
Reactivity
Human (QC Testing)  Mouse (Tested in Development) 
Application
Intracellular staining (flow cytometry) (Routinely Tested) 
Western blot, Immunohistochemistry-paraffin (Tested During Development) 
Immunogen
Human RUNX3 Recombinant Protein
Storage Buffer
Aqueous buffered solution containing ≤0.09% sodium azide.
Regulatory Status
RUO

Regulatory Status Legend

RUO
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
RUO (GMP)
For Research Use Only. Not for use in diagnostic or therapeutic procedures. Although not required, these products are manufactured in accordance with Good Manufacturing Practices.
GPR
General Purpose Reagent
IVD
For In Vitro Diagnostic Use.
ASR
Analyte Specific Reagent. Analytical and performance characteristics are not established.

Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.

Sizes
0.1 mg
Catalog No.
564813
List Price

Your Price

Unit
EA (1 Each)

RUO Certificate Required

This product requires a valid RUO certificate to purchase.


  1. Chuang LS, Ito K, Ito Y. RUNX family: Regulation and diversification of roles through interacting proteins. Int J Cancer. 2013; 132(6):1260-1271. View reference

  2. Djuretic IM, Cruz-Guilloty F, Rao A. Regulation of gene expression in peripheral T cells by Runx transcription factors. Adv Immunol. 2009; 104(1):23. View reference

  3. Ito K, Liu Q, Salto-Tellez M, et al. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res. 2005; 65(17):7743-7750. View reference

  4. Lotem J, Levanon D, Negreanu V, Leshkowitz D, Friedlander G, Groner Y. Runx3-mediated transcriptional program in cytotoxic lymphocytes. PLoS ONE. 2013; 8(11):e80467. View reference

  5. Reis BS, Rogoz A, Costa-Pinto FA, Taniuchi I, Mucida D. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4(+) T cell immunity. Nat Immunol. 2013; 14(3):271-280. View reference

  6. Setoguchi R, Tachibana M, Naoe Y, et al. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell devel. Science. 2008; 19(5864):822-825. View reference

564813 Rev. 1